InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Explore the full record of transactions filed by Betz Stephen F., Directeur Scientifique. Director active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. In total, 29 disclosures have been published. Total volume traded: €3.2m. The latest transaction was disclosed on 2 May 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations29 total
€62,0913,247 shares@ €19.12260.0014% mcap2.0% of flow
Common Stock
SEC:0001209191-22-027145:0·
€135,5885,664 shares@ €23.93850.0030% mcap4.3% of flow
Common Stock
SEC:0001209191-22-025190:0·
€196,5789,000 shares@ €21.8420.0044% mcap6.2% of flow
Common Stock
SEC:0001209191-22-023556:0·
€79,2064,164 shares@ €19.02160.0018% mcap2.5% of flow
Common Stock
SEC:0001209191-22-022036:0·
€54,0523,123 shares@ €17.30760.0012% mcap1.7% of flow
Common Stock
SEC:0001209191-22-019595:0·
016,500 shares0
Common Stock
SEC:0001209191-22-015130:0·
€51,4873,123 shares@ €16.48630.0012% mcap1.6% of flow
Common stock
SEC:0001209191-22-010784:0·
€52,2563,123 shares@ €16.73250.0012% mcap4.1% of flow
Common stock
SEC:0001209191-22-006797·
€52,2563,123 shares@ €16.73250.0012% mcap1.7% of flow
Common stock
SEC:0001209191-22-006797:0·
€85,0734,168 shares@ €20.41090.0019% mcap2.7% of flow
Common stock
SEC:0001209191-22-004051:0·
€85,0734,168 shares@ €20.41090.0019% mcap6.6% of flow
Common stock
SEC:0001209191-22-004051·
€176,5937,168 shares@ €24.63630.0040% mcap13.7% of flow
Common stock
SEC:0001209191-22-002197·
€176,5937,168 shares@ €24.63630.0040% mcap5.6% of flow
Common stock
SEC:0001209191-22-002197:0·
€74,0083,000 shares@ €24.66950.0017% mcap5.8% of flow
Common stock
SEC:0001209191-21-071646·
€74,0083,000 shares@ €24.66950.0017% mcap2.3% of flow
Common stock
SEC:0001209191-21-071646:0·
€121,5015,668 shares@ €21.43630.0027% mcap9.4% of flow
Common stock
SEC:0001209191-21-070272·
€121,5015,668 shares@ €21.43630.0027% mcap3.9% of flow
Common stock
SEC:0001209191-21-070272:0·
€136,9695,668 shares@ €24.16530.0031% mcap10.6% of flow
Common stock
SEC:0001209191-21-067840·
€136,9695,668 shares@ €24.16530.0031% mcap4.3% of flow
Common stock
SEC:0001209191-21-067840:0·
€132,5155,668 shares@ €23.37950.0030% mcap10.3% of flow
Common stock
SEC:0001209191-21-065149·
€132,5155,668 shares@ €23.37950.0030% mcap4.2% of flow
Common stock
SEC:0001209191-21-065149:0·
€304,79012,600 shares@ €24.18970.0069% mcap23.7% of flow
Common stock
SEC:0001209191-21-063679·
€304,79012,600 shares@ €24.18970.0069% mcap9.7% of flow
Common stock
SEC:0001209191-21-063679:0·
€121,5835,668 shares@ €21.45080.0027% mcap9.5% of flow
Common stock
SEC:0001209191-21-062731·
€121,5835,668 shares@ €21.45080.0027% mcap3.9% of flow
Common stock
SEC:0001209191-21-062731:0·
25 of 29 declarations
About Betz Stephen F.
Stephen F. Betz is an executive at Crinetics Pharmaceuticals, Inc.
